5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide

C20H25N3O3 — CID 109102415

IUPAC5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide
SMILESCCC(C)NC(=O)c1cncc(C(=O)Nc2ccc(OC(C)C)cc2)c1
InChIInChI=1S/C20H25N3O3/c1-5-14(4)22-19(24)15-10-16(12-21-11-15)20(25)23-17-6-8-18(9-7-17)26-13(2)3/h6-14H,5H2,1-4H3,(H,22,24)(H,23,25)
InChIKeyJDJYDMXMYXXAHA-UHFFFAOYSA-N
MW355.44 g/mol
LogP3.65
Rot. Bonds7

About 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide

5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide (PubChem CID 109102415) has the molecular formula C20H25N3O3 and a molecular weight of 355.44 g/mol. Its IUPAC name is 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide.

Molecular Properties

Compound Name5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide
PubChem CID109102415
Molecular FormulaC20H25N3O3
Molecular Weight355.44 g/mol
Exact Mass355.19
IUPAC Name5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide
SMILESCCC(C)NC(=O)c1cncc(C(=O)Nc2ccc(OC(C)C)cc2)c1
InChIInChI=1S/C20H25N3O3/c1-5-14(4)22-19(24)15-10-16(12-21-11-15)20(25)23-17-6-8-18(9-7-17)26-13(2)3/h6-14H,5H2,1-4H3,(H,22,24)(H,23,25)
InChIKeyJDJYDMXMYXXAHA-UHFFFAOYSA-N
XLogP3.65
TPSA80.32 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500355.44
LogP ≤ 53.65
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-N-butan-2-yl-3-N-(4-ethylphenyl)pyridine-3,5-dicarboxamide
CID 109102383
3-N-(2-methoxyethyl)-5-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide
CID 109103509
N-[(2S)-butan-2-yl]-4-propan-2-yloxybenzamide
CID 40772005
3-N-(3-acetylphenyl)-5-N-butan-2-ylpyridine-3,5-dicarboxamide
CID 109102422
5-(4-ethylpiperazin-1-yl)-N-(4-propan-2-yloxyphenyl)pyridine-3-carboxamide
CID 109230669
N-[(2S)-butan-2-yl]-4-[(4-methoxybenzoyl)amino]benzamide
CID 42427383
N-butan-2-yl-2-(4-propan-2-yloxyanilino)pyridine-4-carboxamide
CID 109165854
5-(azepan-1-yl)-N-(4-propan-2-yloxyphenyl)pyridine-3-carboxamide
CID 109241366
5-(4-propan-2-ylanilino)-N-(4-propan-2-yloxyphenyl)pyridine-3-carboxamide
CID 109243870
2-(butan-2-ylamino)-N-(4-propan-2-yloxyphenyl)pyridine-4-carboxamide
CID 109165938
5-N-butan-2-yl-3-N-(2-phenoxyphenyl)pyridine-3,5-dicarboxamide
CID 109102453
N-butan-2-yl-4-[[4-(2-methylpropoxy)benzoyl]amino]benzamide
CID 17201290

Frequently Asked Questions

What is the IUPAC name of 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide?
The IUPAC name of 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide (CID 109102415) is 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide.
What is the SMILES notation for 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide?
The canonical SMILES for 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide is CCC(C)NC(=O)c1cncc(C(=O)Nc2ccc(OC(C)C)cc2)c1.
What is the InChIKey of 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide?
The InChIKey is JDJYDMXMYXXAHA-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H25N3O3/c1-5-14(4)22-19(24)15-10-16(12-21-11-15)20(25)23-17-6-8-18(9-7-17)26-13(2)3/h6-14H,5H2,1-4H3,(H,22,24)(H,23,25).
What are the key properties of 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide?
5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide has a molecular weight of 355.44 g/mol, XLogP of 3.65, 7 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-N-butan-2-yl-3-N-(4-propan-2-yloxyphenyl)pyridine-3,5-dicarboxamide is sourced from PubChem (CID 109102415), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).